Evidence map›Paper›PMID 39574842›Full record

ArticlemedRxiv : the preprint server for health sciences2024

International prevalence patterns of low eGFR in adults aged 18-60 without traditional risk factors from population-based cross-sectional studies: a disadvantaged populations eGFR epidemiology (DEGREE) study.

Charlotte E Rutter, Mary Njoroge, Phil Cooper, Prabhakaran Dorairaj, Vivekanand Jha, Prabhdeep Kaur, Sailesh Mohan, Ravi Raju Tatapudi, Annibale Biggeri, Peter Rohloff and 26 more

Abstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

36 authors.

Charlotte E RutterDepartment of Medical Statistics, London School of Hygiene & Tropical Medicine, London, UK.ORCID 0000-0002-9823-7932
Mary NjorogeDepartment of Medical Statistics, London School of Hygiene & Tropical Medicine, London, UK.
Phil CooperInstitute of Infection and Immunity, St George's University of London, UK; School of Medicine, Universidad Internacional del Ecuador, Quito, Ecuador.
Prabhakaran DorairajPublic Health Foundation of India, New Delhi, India.
Vivekanand JhaGeorge Institute for Global Health, UNSW, New Delhi, India; School of Public Health, Imperial College, London, UK; Prasanna School of Public Health, Manipal Academy of Higher Education, Manipal, India.
Prabhdeep KaurIndian Institute of Science, Bengaluru, India.
Sailesh MohanPublic Health Foundation of India, New Delhi, India.
Ravi Raju TatapudiThe Apollo University, Chittoor, Andhra Pradesh, India.
Annibale BiggeriDepartment of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua, Italy.
Peter RohloffCenter for Indigenous Health Research, Maya Health Alliance, Wuqu' Kawoq, Guatemala.
Michelle H HathawayDivision of Environmental and Occupational Health Sciences, School of Public Health, University of Illinois Chicago, USA.
Amelia CrampinMalawi Epidemiology and Intervention Research Unit (MEIRU), Malawi; University of Glasgow, UK.
Meghnath DhimalNepal Health Research Council, Kathmandu, Nepal.
Anil PoudyalNepal Health Research Council, Kathmandu, Nepal.
Antonio Bernabe-OrtizCRONICAS Center of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Peru.ORCID 0000-0002-6834-1376
Cristina O'Callaghan-GordoFaculty of Health Sciences, Universitat Oberta de Catalunya, Barcelona, Spain; ISGlobal, Barcelona, Spain; Universitat Pompeu Fabra, Barcelona, Spain; CIBER Epidemiología y Salud Pública, Madrid, Spain.
Pubudu ChulasiriMinistry of Health, Sri Lanka.
Nalika GunawardenaWHO Regional Office, New Delhi, India.
Thilanga RuwanpathiranaMinistry of Health, Sri Lanka.
S C WickramasingheMinistry of Health, Sri Lanka.
Sameera SenanayakeDuke-NUS Medical School, Singapore.
Chagriya KitiyakaraFaculty of Medicine Ramathibodi Hospital, Mahidol University, Thailand.
Marvin Gonzalez-QuirozDepartment of Environmental and Occupational Health, UT School of Public Health San Antonio, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.
Sandra CortésAdvanced Center for Chronic Diseases (ACCDiS), Faculty of Medicine, Pontifical Catholic University of Chile, Santiago, Chile.
Kristina JakobssonSchool of Public Health and Community Medicine, University of Gothenburg, Sweden.
Ricardo Correa-RotterInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico; National Autonomous University of Mexico, Mexico.
Jason GlaserLa Isla Network, Ada, Michigan, USA.
Ajay SinghHarvard University, USA.
Sophie HamiltonDepartment of Epidemiology and Biostatistics, Imperial College London, London, UK.
Devaki NairCentre for Kidney and Bladder Health, University College London, London, UK.
Aurora AragónWuqu' Kawoq Maya Health Alliance, Chimaltenango, Guatemala.
Dorothea NitschDepartment of Non-communicable Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
Steven RobertsonClinical Trials Unit, London School of Hygiene & Tropical Medicine, London, UK.
Ben CaplinCentre for Kidney and Bladder Health, University College London, London, UK.
Neil PearceDepartment of Medical Statistics, London School of Hygiene & Tropical Medicine, London, UK.
DEGREE Study Group

Funding

Occupational Safety and Health, ERC, University of Illinois at ChicagoT42OH008672 · OH · UNIVERSITY OF ILLINOIS AT CHICAGO · PI BUCHANAN, SUSAN NATHALIE · 2005 to 2025
$32.7M
Building Capacity for Chronic Kidney Disease Research in Guatemala.R21TW010831 · FIC · BRIGHAM AND WOMEN'S HOSPITAL · PI MENDOZA, CARLOS, ROHLOFF, PETER · 2017 to 2018
$335k
FIC NIH HHS R21 TW010831NIOSH CDC HHS T42 OH008672
6 · The paper itself

Abstract

The disadvantaged populations eGFR (estimated glomerular filtration rate) epidemiology (DEGREE) study was designed to gain insight into the burden of chronic kidney disease (CKD) of undetermined cause (CKDu) using standard protocols to estimate the general-population prevalence of low eGFR internationally. We estimated the age-standardised prevalence of eGFR<60ml/min/1.73m

Indexed as

CINACKDntCKDueGFRMeNprevalence

Identifiers

PMID39574842
PMCPMC11581094

What Socratic holds

Textmetadata
LicenceCC BY-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.